Aprea Therapeutics Inc.

NASDAQ: APRE · Real-Time Price · USD
1.71
0.02 (1.18%)
At close: Aug 15, 2025, 3:59 PM
1.67
-2.54%
After-hours: Aug 15, 2025, 07:38 PM EDT

Aprea Therapeutics Cash Flow Statement

Financials in USD. Fiscal year is January - December.
Fiscal Year Q2 2025 Q1 2025 Q4 2024 Q3 2024 Q2 2024 Q1 2024 Q4 2023 Q3 2023 Q2 2023 Q1 2023 Q4 2022 Q3 2022 Q2 2022 Q1 2022 Q4 2021 Q3 2021 Q2 2021 Q1 2021
Period Ending Jun 30, 2025 Mar 31, 2025 Dec 31, 2024 Sep 30, 2024 Jun 30, 2024 Mar 31, 2024 Dec 31, 2023 Sep 30, 2023 Jun 30, 2023 Mar 31, 2023 Dec 31, 2022 Sep 30, 2022 Jun 30, 2022 Mar 31, 2022 Dec 31, 2021 Sep 30, 2021 Jun 30, 2021 Mar 31, 2021
Net Income
-3.24M -3.93M -2.89M -3.78M -3.47M -2.81M -3.44M -3.2M -3.26M -4.38M -2.44M -4.02M -98.26M -7.94M -7.76M -9.45M -10.25M -9.67M
Depreciation & Amortization
5.43K 5.43K 5.43K 5.43K 5.3K 6.16K 4.99K 1.43K 224.00 410.00 -2.38K 61.37K 63.69K 63.77K 65.99K 69.44K 60.24K 76K
Stock-Based Compensation
136.73K 118.63K 126.03K 149.09K 128.49K 85.83K 82.86K 76.03K 269.32K 16.24K 57.35K 38.24K 14.8M 2.08M 2.09M 2.04M 1.86M 1.82M
Other Working Capital
38.16K 197.56K -910.13K 947.47K 52.76K -811.36K -1.23M 1.15M -477.32K 16.73K -1.37M 210.51K 48.27K 214.77K -3.74M -1.1M 1.42M -2.18M
Other Non-Cash Items
25.87K 51.8K -39.19K 35.49K 88.15K -56.18K -791.39K 155.87K -56.36K 13.8K 33.6K -24.35K 72.37M -136.21K -70.17K 21.91K 252.84K -521.98K
Deferred Income Tax
n/a n/a n/a n/a n/a n/a 709.2K n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a
Change in Working Capital
-59.91K 125.63K -708.38K 1.13M -290.93K -1.16M -425.63K 882.21K -170.99K 1.37M -1.67M -2.64M 2.12M 429.75K -4.51M -908.99K 322.55K -3.23M
Operating Cash Flow
-3.13M -3.63M -3.51M -2.47M -3.54M -3.94M -3.86M -2.09M -3.22M -2.98M -4.02M -6.59M -8.9M -5.5M -10.18M -8.23M -7.75M -11.52M
Capital Expenditures
n/a n/a 380.49 -209 -7.29K -7.98K -8.56K -84.08K n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a
Cash Acquisitions
n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a
Purchase of Investments
n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a
Sales Maturities Of Investments
n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a
Other Investing Acitivies
n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a
Investing Cash Flow
n/a n/a 384.41 -209 -7.29K -7.98K -8.56K -84.08K 24.84K n/a n/a n/a n/a n/a n/a n/a n/a n/a
Debt Repayment
n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a
Common Stock Repurchased
n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a
Dividend Paid
n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a
Other Financial Acitivies
-22.92K n/a -6.35K -280.84K n/a -1.29M n/a n/a -24.84K -648.93K n/a n/a n/a n/a 1.66M 86.97K n/a n/a
Financial Cash Flow
384.88K 55.85K 134.41K -1.16K -219.92K 14.71M 86.38K -86.59K -24.84K 5.14M 98.53K 584.45K n/a n/a 1.66M 86.97K n/a n/a
Net Cash Flow
-2.74M -3.57M -3.4M -2.44M -3.68M 10.76M -3.75M -2.33M -3.27M 2.21M -4.33M -5.95M -8.59M -5.42M -8.35M -8.38M -7.81M -11.4M
Free Cash Flow
-3.13M -3.63M -3.51M -2.47M -3.55M -3.94M -3.87M -2.33M -3.22M -2.98M -4.02M -6.59M -8.9M -5.5M -10.18M -8.23M -7.75M -11.52M